CClinicalTrials.gg
CompletedNCT01388634LOSHERNIAUpdated Jun 27, 2018

Prolonged Hospital Stay and Readmission After Elective Ventral Hernia Repair

An observational study in Ventral Hernia, sponsored by Zealand University Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-06-27.

Sponsored by Zealand University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
2,258
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the present study was to analyse factors associated with prolonged length of hospital stay, readmission and death in a nationwide group of patients undergoing elective ventral hernia repair in search for areas of interest to improve outcome after ventral hernia surgery

Read the detailed description

Detailed analysis of reasons for prolonged hospital stay and readmission in patients undergoing a ventral hernia repair

02

Conditions studied

  • Ventral Hernia

Keywords

  • Length of hospital stay
  • readmission
  • ventral hernia
03

In context

Hernia

1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.

This study's enrollment of 2,258 is above the median of 120 across 327 observational studies indexed under Hernia.

Browse Hernia studies →

Lead sponsor

Zealand University Hospital is the lead sponsor of 234 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients registered in The Danish Ventral Hernia Database in 2008

Inclusion criteria

  • patients with elective ventral hernia repair in Denmark 2008

Exclusion criteria

Exclusion Criteria:

  • emergency repairs
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
2,258 participants (actual)

Groups and cohorts

  • Study cohort

    Patients with prolonged length of hospital stay (\>5 days) or readmission after ventral hernia repair

  • control group

    Patients without prolonged length of hospital stay (\>5 days) or readmission after ventral hernia repair

06

What researchers measure

Primary outcomes

  1. Length of hospital stay

    analyse factors associated with prolonged length of hospital stay (minimum 5 days).

    Time frame: participants will be followed for the duration of hospital stay, an expected average of 1 week

Secondary outcomes

  1. Readmission

    reasons for readmission after a ventral hernia repair

    Time frame: 30 days

07

Study locations

1 site
  • Dept. of surgery, Køge Hospital
    Køge, 4600, Denmark
08

References and documents

Publications

  • Helgstrand F, Rosenberg J, Kehlet H, Bisgaard T. Nationwide analysis of prolonged hospital stay and readmission after elective ventral hernia repair. Dan Med Bull. 2011 Oct;58(10):A4322. PubMed 21975153 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01388634
Lead sponsor
Zealand University Hospital
Responsible party
Frederik Helgstrand (MD, Zealand University Hospital) — Principal investigator
First posted
Jul 6, 2011
Start date
Jun 2010
Primary completion
Dec 2010
Completion
Aug 2011
Last update
Jun 27, 2018

Study contacts

Frederik Helgstrand, MD
principal investigator · Dept. surgery Køge hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion